Evidence map›Paper›PMID 35593915›Full record

Trial reportCannabis and cannabinoid research2023

Effects of Oral Delta-9-Tetrahydrocannabinol in Women During the Follicular Phase of the Menstrual Cycle.

Elisa Pabon, Harriet de Wit

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Cannabis and cannabinoid research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Elisa PabonDepartment of Psychiatry and Behavioral Neuroscience, University of Chicago Medical Center, Chicago, Illinois, USA.ORCID 0000-0001-6669-7259
Harriet de WitDepartment of Psychiatry and Behavioral Neuroscience, University of Chicago Medical Center, Chicago, Illinois, USA.
University of Chicago Medical Center · US

Funding

University of Chicago Initiative for Maximizing Student Development (IMSD) - Renewal 01R25GM109439 · NIGMS · UNIVERSITY OF CHICAGO · PI SCHWARTZ, NANCY B · 2014 to 2023
$5.7M
Integrative Training in the Neurobiology of Addictive BehaviorsT32DA043469 · NIDA · UNIVERSITY OF CHICAGO · PI Donald Hedeker, Xiaoxi Zhuang · 2017 to 2026
$3.8M
Differential female response to delta-9-tetrahydrocannabinol (THC)F31DA049391 · NIDA · UNIVERSITY OF CHICAGO · PI PABON, ELISA · 2020 to 2021
$92k
NIDA NIH HHS F31 DA049391NIDA NIH HHS T32 DA043469NIGMS NIH HHS R25 GM109439
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DronabinolFollicular PhaseEstrogensFemaleHumansMenstrual CycleDronabinolEstrogensdelta-9-tetrahydrocannabinolestradiolfollicular phasemenstrual cycleprogesterone

Identifiers

PMID35593915
PMCPMC10714110
OpenAlexW4281259079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.